Private umbilical cord blood banking: a biological insurance of dubious future benefit!

摘要: criticisms” “If commercial banks are allowed (in any EU member state), appropriate information should be given to consumers willing use their services, including the fact that likelihood samples may used treat one’s child is currently negligible, future therapeutic possibilities of a very hypothetical nature, and up until now there no indication present research will lead specific applications on own cord blood cells” “… particularly explicit, auto conservation has little value in current state scientific knowledge. This made clear all media, Internet, contracts linking customers” A private, for-profit umbilical bank was launched New Zealand 2003. Like other private (CellSence, Australia, CordBlood Registry, Canada), CordBank offers expectant parents service for autologous collection storage baby’s treatment lifethreatening diseases (http://www.cordbank.co.nz). Promoted as an “insurance future”, publicise services based successful allogeneic stem cell transplantation from public unrelated banks, but frequently do not make it crucial distinction between transplantation. Private also promote banking “once life time opportunity” store cells degenerative disease, without significant evidence (as opposed cells) offer unique benefits this purpose. To informed choice, assess themselves storage, need provided with independent accurate by midwives GPs. Unfortunately, only available most themselves, which often inaccurate confusing: • http://www.cordbank.co.nz/why/ http://www.cordblood.com/ http://www.cellsense.com.au